Future prospects for bladder cancer biomarkers.
St George's Hospital, London, UK. saheel.mukhtar@stgeorges.nhs.uk
Saheel
S
Mukhtar
Matthew J A
MJ
Perry
D014408:Biomarkers, Tumor / Q000378:metabolism*; D018797:Cell Cycle Proteins / Q000378:metabolism; D005544:Forecasting; D006801:Humans; D064111:Minichromosome Maintenance Complex Component 2; D009687:Nuclear Proteins / Q000378:metabolism; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism; D051498:Receptor, Fibroblast Growth Factor, Type 3 / Q000378:metabolism; D001749:Urinary Bladder Neoplasms / Q000175:diagnosis*
D014408:Biomarkers, Tumor; D018797:Cell Cycle Proteins; D064111:Minichromosome Maintenance Complex Component 2; D009687:Nuclear Proteins; D018719:Erb-b2 Receptor Tyrosine Kinases; D051498:Receptor, Fibroblast Growth Factor, Type 3; C489423:MCM5 protein, human; C084859:MCM2 protein, human